An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease. This breakthrough, detailed in a new ...
A woman developed 12 tumors — seven benign and five cancerous — before her 40th birthday. Medical researchers recently discovered why she's so prone to the abnormal growths: She carries a set of ...
ANN ARBOR, Mich. — A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Hosted on MSN
Data analysis reveals 1 in 12 patients with multiple cancers carries inherited genetic risk
A new study reveals that about one in 12 patients who are diagnosed with two or more different types of cancer were born with a mutation in a known cancer risk gene. This discovery could reshape how ...
When Timothy Yu developed milasen, a custom drug for a young girl named Mila with Batten disease, he ignited a spark in the field of personalized medicine. Milasen was the first medicine specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results